AI Article Synopsis

  • β-arrestin 1 (ARRB1) is vital for bladder cancer stem cells' metabolism, influencing their growth and tumor formation.
  • Deletion of ARRB1 lowers glycolysis and shifts energy production toward oxidative phosphorylation by increasing MPC1 and decreasing GLUT1 levels.
  • Overexpressing ARRB1 in knock-out cells restores glycolytic activity, suggesting that targeting ARRB1 could be a new treatment strategy for bladder cancer.

Article Abstract

β-arrestin 1 (ARRB1) is a scaffold protein that regulates signaling downstream of G protein-coupled receptors (GPCRs). In the current work, we investigated the role of ARRB1 in regulating the metabolic preference of cancer stem cell (CSC)-like cells in bladder cancer (BC). We show that ARRB1 is crucial for spheroid formation and tumorigenic potential. Furthermore, we measured mitochondrial respiration, glucose uptake, glycolytic rate, mitochondrial/glycolytic ATP production and fuel oxidation in previously established ARRB1 knock out (KO) cells and corresponding controls. Our results demonstrate that depletion of ARRB1 decreased glycolytic rate and induced metabolic reprogramming towards oxidative phosphorylation. Mechanistically, the depletion of ARRB1 dramatically increased the mitochondrial pyruvate carrier MPC1 protein levels and reduced the glucose transporter GLUT1 protein levels along with glucose uptake. Overexpression of ARRB1 in ARRB1 KO cells reversed the phenotype and resulted in the upregulation of glycolysis. In conclusion, we show that ARRB1 regulates the metabolic preference of BC CSC-like cells and functions as a molecular switch that promotes reprogramming towards glycolysis by negatively regulating MPC1 and positively regulating GLUT1/ glucose uptake. These observations open new therapeutic avenues for targeting the metabolic preferences of cancer stem cell (CSC)-like BC cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069028PMC
http://dx.doi.org/10.3390/cancers13081809DOI Listing

Publication Analysis

Top Keywords

csc-like cells
12
glucose uptake
12
arrb1
10
arrb1 regulates
8
regulates metabolic
8
metabolic reprogramming
8
bladder cancer
8
metabolic preference
8
cancer stem
8
stem cell
8

Similar Publications

Background: Cancer stem cells (CSCs) constitute a small and elusive subpopulation of cancer cells within a tumor mass and are characterized by stem cell properties. Reprogrammed CSCs exhibit similar capability to initiate tumor growth, metastasis, and chemo- and radio-resistance and have similar gene profiles to primary CSCs. However, the efficiency of cancer cell reprogramming remained relatively low.

View Article and Find Full Text PDF

Tetramethylpyrazine attenuates the cancer stem cell like-properties and doxorubicin resistance by targeting HMGCR in breast cancer.

Phytomedicine

December 2024

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine (TCM) Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, PR China. Electronic address:

Background: Tetramethylpyrazine (TMP), a key bioactive constituent derived from Ligusticum wallichii Franchat, has demonstrated efficacy in mitigating multidrug resistance (MDR) in human breast cancer (BC) cells. However, the precise mechanisms underlying its action remain poorly understood.

Purpose: Cancer stem cells (CSCs) are widely recognized as the primary contributors to MDR.

View Article and Find Full Text PDF

Cancer stem cells (CSCs) have been implicated as critical mediators in the progression, chemoresistance and metastatic capabilities of diverse malignancies, including osteosarcoma (OS). The authors have succeeded in generating CSC‑like cells (MG‑OKS) from the OS cell line MG‑63 by transducing defined factors. A significant increase in small proline‑rich protein 1A (SPRR1A) expression, a cross‑linked envelope protein in keratinocytes, was observed in MG‑OKS cells.

View Article and Find Full Text PDF
Article Synopsis
  • MACC1 is a newly identified factor in lung cancer that promotes the transition of non-cancer stem cells (non-CSCs) to cancer stem cells (CSCs), which play a key role in tumor growth.
  • High levels of MACC1 are found in stemness-enriched lung cancer cells, and reducing MACC1 expression through shRNA effectively halts this transition.
  • The study suggests that MACC1 stabilizes KLF4 mRNA by inhibiting microRNA-25, and understanding this relationship could lead to targeted therapies for cancer stem cells.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on understanding the mechanisms behind the cholangiocellular phenotype (CCA) in hepatocellular carcinoma (HCC), particularly the roles of specific cell types in tumor progression.
  • Utilizing single-cell RNA sequencing, researchers identified a unique subset of senescent endothelial cells (CD34CLDN5 ECs) that promote tumor growth by secreting IGF2, which attracts mesenchymal stem cells (MSCs) to the tumor microenvironment.
  • The interaction between these senescent ECs and MSCs was shown to enhance cancer malignancy, revealing potential targets for therapeutic intervention in HCC.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!